Publications by authors named "Peter Sandercock"

Claim this Profile
L
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
Peter Kelly, Robin Lemmens, Christian Weimar, Cathal Walsh, Francisco Purroy, Peter Sandercock

Lancet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19.
Peter A G Sandercock, Janet Darbyshire, David DeMets, Robert Fowler, David G Lalloo

Trials· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the use of different methods of consent in a randomized acute stroke trial: The Third International Stroke Trial (IST-3).
Richard I Lindley, Ingrid Kane, Geoff Cohen, Peter Ag Sandercock

Int J Stroke· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
Rustam Al-Shahi Salman, Martin S Dennis, Peter A G Sandercock, Cathie L M Sudlow, Joanna M Wardlaw

JAMA Neurol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials.
Lisa J Woodhouse, Alan A Montgomery, Jonathan Mant, Barry R Davis, Ale Algra, Peter Sandercock

BMC Med Res Methodol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and diagnostic accuracy of using brain attenuation changes on CT to estimate time of ischemic stroke onset.
Grant Mair, Awad Alzahrani, Richard I Lindley, Peter A G Sandercock, Joanna M Wardlaw

Neuroradiology· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke.
Simiao Wu, Grant Mair, Geoff Cohen, Zoe Morris, Anders von Heijne, Peter A G Sandercock

Stroke Vasc Neurol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trial.
Peter Kelly, Christian Weimar, Robin Lemmens, Sean Murphy, Francisco Purroy, Peter Sandercock

Eur Stroke J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conceptual framework for establishing the African Stroke Organization.
Rufus Akinyemi, Fred Sarfo, Foad Abd-Allah, Yomi Ogun, Mofou Belo, Peter Sandercock

Int J Stroke· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Amy Brenner, Antonio Belli, Rizwana Chaudhri, Timothy Coats, Lauren Frimley, Peter Sandercock

Crit Care· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eivind Berge, MD, PhD, 1964-2020: Cardiologist Who Was Fighting Stroke.
Sverre E Kjeldsen, Sigrun Halvorsen, Torgeir Bruun Wyller, Philip M Bath, Peter Sandercock

Stroke· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Clinical Detection of Acute Lacunar Stroke: Analysis From the IST-3.
Francesco Arba, Grant Mair, Stephen Phillips, Peter Sandercock, Joanna M Wardlaw

Stroke· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.
Martin Dennis, John Forbes, Catriona Graham, Maree Hackett, Graeme J Hankey, Peter Sandercock

Health Technol Assess· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Independent Testing of e-ASPECTS Software (RITeS): statistical analysis plan.
Grant Mair, Francesca Chappell, Chloe Martin, David Dye, Philip M Bath, Peter A G Sandercock

AMRC Open Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical diagnosis of TIA or minor stroke and prognosis in patients with neurological symptoms: A rapid access clinic cohort.
Catriona Graham, David Bailey, Simon Hart, Aidan Hutchison, Peter Sandercock

PLoS One· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoxetine and Fractures After Stroke: Exploratory Analyses From the FOCUS Trial.
Martin Dennis, John Forbes, Catriona Graham, Maree L Hackett, Graeme J Hankey, Peter Sandercock

Stroke· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top 10 global educational topics in stroke: A survey by the World Stroke Organization.
Monica Saini, Sarah Belson, Carmen Lahiff-Jenkins, Peter Sandercock

Int J Stroke· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can the World Stroke Organization (WSO) optimize education in stroke medicine around the world? Report of the 2018 WSO Global Stroke Stakeholder Workshop.
Gord Gubitz, Monica Saini, Sarah Belson, Ramesh Sahathevan, Peter Sandercock

Int J Stroke· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
Rustam Al-Shahi Salman, David P Minks, Dipayan Mitra, Mark A Rodrigues, Priya Bhatnagar, Peter A G Sandercock

Lancet Neurol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke in China: advances and challenges in epidemiology, prevention, and management.
Simiao Wu, Bo Wu, Ming Liu, Zhengming Chen, Wenzhi Wang, Peter Sandercock

Lancet Neurol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial.
Rustam Al-Shahi Salman, Gordon D Murray, Martin S Dennis, David E Newby, Peter A G Sandercock

Trials· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
World Stroke Day.
Peter Sandercock

Stroke· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke.
Grant Mair, Rüdiger von Kummer, Zoe Morris, Anders von Heijne, Nick Bradey, Peter A G Sandercock

Neurology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
World Stroke Day - a day of global action.
Peter Sandercock

Int J Stroke· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Rating Scales of White Matter Hyperintensities and Atrophy: Comparison of Computed Tomography and Magnetic Resonance Imaging.
Karen J Ferguson, Vera Cvoro, Alasdair M J MacLullich, Susan D Shenkin, Peter A G Sandercock

J Stroke Cerebrovasc Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis